Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Meitu Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of dermatological products and active pharmaceutical ingredients. Based in Shijiazhuang, the company focuses on external preparations such as creams, ointments, and gels for treating skin conditions like acne, bacterial infections, and inflammatory disorders. Their portfolio includes widely used treatments such as Adapalene, Tretinoin, and Mupirocin, produced in GMP-certified facilities. Meitu Pharmaceutical integrates advanced manufacturing technologies with a robust R&D framework to supply high-quality topical medications to the healthcare sector. The company is recognized as a key player in the regional pharmaceutical industry, emphasizing quality control and technological innovation in skin health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Meitu Pharmaceutical.